Chronic kidney disease among the Iranian-Azari population; a report from pilot phase of AZAR cohort study

Chronic kidney disease among the Iranian-Azari population; a report from pilot phase of AZAR cohort study


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: فریبا محمودپور , محمد رضا اردلان , محمد حسین صومی , الناز فرامرزی , سپیده زنونی واحد , موسی غیور نهند

کلمات کلیدی: Renal diseases Chronic kidney disease Persian cohort End-stage renal disease

نشریه: 0 , 3 , 7 , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله فریبا محمودپور
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشگاه علوم پزشکی تبریز
کد مقاله 57278
عنوان فارسی مقاله Chronic kidney disease among the Iranian-Azari population; a report from pilot phase of AZAR cohort study
عنوان لاتین مقاله Chronic kidney disease among the Iranian-Azari population; a report from pilot phase of AZAR cohort study
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق) journal of renal injury prevention
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح سه – Scopus
آدرس لینک مقاله/ همایش در شبکه اینترنت khg54trrrttttttttttttttttt

خلاصه مقاله
hide/show

Introduction: Chronic kidney disease (CKD) is a worldwide health problem. Most patients with CKD are asymptomatic and unaware of their disease until reaches its latter stages. The worldwide prevalence of CKD is increasing and delayed diagnosis takes from the patients the opportunities for early treatment. Objectives: Our cohort, named AZAR cohort, is a part of a national cohort program and it is aimed to study the major cardiovascular, pulmonary, renal, diabetes, and cancers diseases risk factors in East-Azerbaijan province in North West of Iran. Patients and Methods: In this cross-sectional study, all eligible subjects (35-65 years) were recruited. Information about demographic, medical history, some physical and para-clinical were collected. Here, we report the results of pilot phase of this study. Results: Findings showed that prevalence of CKD (stage 3, eGFR<60 mL/min) among our studied population was 8% (71/898). The studied population was ranged from young adult to pre-elderly (35-65 years). We found a higher proportion of CKD in women (M/F 14/57). The total proportion of diabetics in our study was 126 persons (14%). Distribution of different stages of CKD was as follows: stage 3A (67 persons, M/F; 14/53), stage 3B (4 females), stage 2 (737 persons, M/F; 328/409) and stage 1 (88 persons, M/F; 64/24). There were no cases of CKD stage 4 or 5 in our cohort. Body mass index (BMI), serum triglyceride (TG), and cholesterol levels had a significant correlation with CKD stage 3 (P < 0.05). Diabetic patients and female gender were at increased risk of CKD stage 3 (OR: 1.5; 95% CI: 0.857-2.861). Conclusion: The prevalence of CKD stage 3 in our cohort was compatible with other previous publications. The higher prevalence of CKD in middle aged to early elderly women population could be explained by the high prevalence of obesity among this population.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
فریبا محمودپوراول
محمد رضا اردلاندوم
محمد حسین صومیسوم
الناز فرامرزیچهارم
سپیده زنونی واحدپنجم
موسی غیور نهندششم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Cohort.pdf1397/05/16362352دانلود